Review of palonosetron: emerging data distinguishing it as a novel 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting

Author： Saito Mitsue   Tsukuda Mamoru  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.6, 2010-04, pp. : 1003-1014

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Palonosetron for chemotherapy-induced nausea and vomiting

By  

Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis

By Grunberg Steven M   Koeller James M  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2297-2303

Informa Healthcare

Access to resources Recommend Favorite

5-HT Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparison of Their Pharmacology and Clinical Efficacy

By Gregory R.E.   Ettinger D.S.  

Drugs, Vol. 55, Iss. 2, 1998-02 ,pp. : 173-189

Adis International

Access to resources Recommend Favorite

New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron

By Tonini Giuseppe   Vincenzi Bruno   Santini Daniele  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 1, 2005-06 ,pp. : 143-149

Informa Healthcare

Access to resources Recommend Favorite

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

By Navari Rudolph M  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1977-1985

Informa Healthcare

Access to resources Recommend Favorite